Evidence map›Paper›PMID 27177915›Full record

Observational studyJournal of general internal medicine2016

Effects of Global Payment and Accountable Care on Tobacco Cessation Service Use: An Observational Study.

Haiden A Huskamp, Shelly F Greenfield, Elizabeth A Stuart, Julie M Donohue, Kenneth Duckworth, Elena M Kouri, Zirui Song, Michael E Chernew, Colleen L Barry

Abstract readObservational Study
In one paragraph

Observational study in Journal of general internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Addiction-25 Years Later.Harvard review of psychiatry
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Haiden A HuskampDepartment of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA. huskamp@hcp.med.harvard.edu.
Shelly F GreenfieldMcLean Hospital, Belmont, MA, USA.
Elizabeth A StuartJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Julie M DonohueUniversity of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
Kenneth DuckworthBlue Cross Blue Shield of Massachusetts, Boston, MA, USA.
Elena M KouriDepartment of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA.
Zirui SongMassachusetts General Hospital, Boston, MA, USA.
Michael E ChernewDepartment of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA, 02115, USA.
Colleen L BarryJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Funding

Substance Use Disorder Treatment under New Payment and Delivery System ModelsR01DA035214 · NIDA · HARVARD MEDICAL SCHOOL · PI BARRY, COLLEEN L, HUSKAMP, HAIDEN A. · 2013 to 2015
$2.2M
Mentoring in Substance Abuse Treatment ResearchK24DA019855 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI GREENFIELD, SHELLY F. · 2005 to 2014
$1.8M
Provider Payment Reform and Implications for Health Care CostsF30AG039175 · NIA · HARVARD MEDICAL SCHOOL · PI SONG, ZIRUI · 2010 to 2014
$161k
NIA NIH HHS F30 AG039175NIDA NIH HHS K24 DA019855NIDA NIH HHS R01 DA035214
6 · The paper itself

Abstract

backgroundTobacco use is the leading cause of preventable death and disability. New payment and delivery system models including global payment and accountable care have the potential to increase use of cost-effective tobacco cessation services.

objectiveTo examine how the Alternative Quality Contract (AQC) established in 2009 by Blue Cross Blue Shield of Massachusetts (BCBSMA) has affected tobacco cessation service use.

designWe used 2006-2011 BCBSMA claims and enrollment data to compare adults 18-64 years in AQC provider organizations to adults in non-AQC provider organizations. We examined the AQC's effects on all enrollees; a subset at high risk of tobacco-related complications due to certain medical conditions; and behavioral health service users. MAIN MEASURES: We examined use of: (1) any cessation treatment (pharmacotherapy or counseling); (2) varenicline or bupropion; (3) nicotine replacement therapies (NRTs); (4) cessation counseling; and (4) combination therapy (pharmacotherapy plus counseling). We also examined duration of pharmacotherapy use and number of counseling visits among users. KEY

resultsRates of tobacco cessation treatment use were higher following implementation of the AQC relative to the comparison group overall (2.02 vs. 1.87 %, p < 0.0001), among enrollees at risk for tobacco-related complications (4.97 vs. 4.66 %, p < 0.0001), and among behavioral health service users (3.67 vs. 3.25 %, p < 0.0001). Statistically significant increases were found for use of varenicline or bupropion alone, counseling alone, and combination therapy, but not for NRT use, pharmacotherapy duration, or number of counseling visits among users.

conclusionsIn its initial three years, the AQC was associated with increases in use of tobacco cessation services.

Indexed as

Accountable Care OrganizationsAdolescentAdultAmbulatory Care FacilitiesBlue Cross Blue Shield Insurance PlansCounselingFemaleHumansMaleMassachusettsMiddle AgedQuality ImprovementReimbursement, IncentiveSmokingTobacco Use CessationTobacco Use Cessation Devicesaccountable careglobal paymenttobacco cessation

Identifiers

PMID27177915
PMCPMC5023596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.